Fatal	fatal	O	O
aplastic	aplastic	O	B_disease
anemia	anemia	O	S_disease
due	due	O	O
to	to	O	O
indomethacin	indomethacin	S_chemical	O
--	--	O	O
lymphocyte	lymphocyte	O	O
transformation	transformation	O	O
tests	tests	O	O
in	in	O	O
vitro	vitro	O	O
.	.	O	O

Although	although	O	O
indomethacin	indomethacin	S_chemical	O
has	has	O	O
been	been	O	O
implicated	implicated	O	O
as	as	O	O
a	a	O	O
possible	possible	O	O
cause	cause	O	O
of	of	O	O
aplastic	aplastic	O	B_disease
anemia	anemia	O	S_disease
on	on	O	O
the	the	O	O
basis	basis	O	O
of	of	O	O
a	a	O	O
few	few	O	O
clinical	clinical	O	O
observations	observations	O	O
,	,	O	O
its	its	O	O
role	role	O	O
has	has	O	O
not	not	O	O
been	been	O	O
definitely	definitely	O	O
established	established	O	O
.	.	O	O

A	a	O	O
case	case	O	O
of	of	O	O
fatal	fatal	O	O
aplastic	aplastic	O	B_disease
anemia	anemia	O	S_disease
is	is	O	O
described	described	O	O
in	in	O	O
which	which	O	O
no	no	O	O
drugs	drugs	O	O
other	other	O	O
than	than	O	O
allopurinol	allopurinol	O	O
and	and	O	O
indomethacin	indomethacin	S_chemical	O
were	were	O	O
given	given	O	O
.	.	O	O

Indomethacin	indomethacin	S_chemical	O
was	was	O	O
first	first	O	O
given	given	O	O
four	four	O	O
weeks	weeks	O	O
prior	prior	O	O
to	to	O	O
the	the	O	O
onset	onset	O	O
of	of	O	O
symptoms	symptoms	O	O
.	.	O	O

A	a	O	O
positive	positive	O	O
lymphocyte	lymphocyte	O	O
transformation	transformation	O	O
test	test	O	O
with	with	O	O
indomethacin	indomethacin	S_chemical	O
in	in	O	O
vitro	vitro	O	O
further	further	O	O
substantiates	substantiates	O	O
the	the	O	O
potential	potential	O	O
role	role	O	O
of	of	O	O
this	this	O	O
drug	drug	O	O
in	in	O	O
causing	causing	O	O
aplastic	aplastic	O	B_disease
anemia	anemia	O	S_disease
in	in	O	O
a	a	O	O
susceptible	susceptible	O	O
patient	patient	O	O
.	.	O	O

Fortunately	fortunately	O	O
,	,	O	O
this	this	O	O
seems	seems	O	O
to	to	O	O
be	be	O	O
a	a	O	O
very	very	O	O
rare	rare	O	O
complication	complication	O	O
.	.	O	O

